Ticker

Neurocrine's reported biotech buy, Coinbase's new regulatory approval, and more

Shares of Aritzia Inc. (OTCMKTS:ATZAF - Get Free Report) have earned a consensus rating of "Buy" from the eight brokerages that are currently covering the firm, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation. A number of research analysts recently issued reports on ATZAF shares. Canadian Imperial Bank of

VANCOUVER, BC, Feb. 27, 2026 /PRNewswire/ - Aritzia Inc. (TSX: ATZ) "Aritzia", the "Company", "we" or "our") today announced that, in connection with its previously announced normal course issuer bid ("NCIB") to purchase up to 4,226,994 of its subordinate voting shares ("Shares") during the twelve month period beginning May 7, 2025 and ending May 6, 2026, it has entered into a new automatic share purchase plan…

Aritzia Inc. (OTCMKTS:ATZAF - Get Free Report) has received an average recommendation of "Buy" from the eight brokerages that are covering the stock, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy rating. A number of research firms have commented on ATZAF. Raymond James Financial reaffirmed an "outperform" rating on shares of

Aritzia is rated a buy, driven by robust US-led growth and expanding digital engagement. ATZAF's US revenue surged 53.8% y/y in Q3 2026, with management raising US store targets to 180–200 locations. Operating leverage is strong: Q3 2026 adj. EBITDA grew 52.2% y/y, with margin expansion despite tariff headwinds.